Quick Answer
HARVARD BIOSCIENCE INC reported Cash And Cash Equivalents At Carrying Value of $8.61 million for the year ending 2025.
- HARVARD BIOSCIENCE INC showed an increase of +109.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from HARVARD BIOSCIENCE INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), HARVARD BIOSCIENCE INC's Cash And Cash Equivalents At Carrying Value has declined by 37.1%.
- Historical annual values: Fiscal year 2025: $8.61 million | Fiscal year 2024: $4.11 million | Fiscal year 2023: $4.28 million | Fiscal year 2022: $4.51 million | Fiscal year 2021: $7.82 million | Fiscal year 2020: $8.32 million | Fiscal year 2019: $8.34 million | Fiscal year 2018: $8.17 million | Fiscal year 2017: $5.19 million | Fiscal year 2016: $5.60 million | Fiscal year 2015: $6.74 million | Fiscal year 2014: $14.13 million | Fiscal year 2013: $25.77 million | Fiscal year 2012: $20.68 million | Fiscal year 2011: $17.92 million | Fiscal year 2010: $19.70 million | Fiscal year 2009: $16.59 million | Fiscal year 2008: $13.70 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: